Faber O K
Acta Endocrinol Suppl (Copenh). 1985;272:73-7. doi: 10.1530/acta.0.110s073.
Beta-cell function, as evaluated from plasma C-peptide measurements, is found in all insulin dependent diabetic patients the first months of disease and in about 15% of patients with more than 15 years of treatment. The beta-cells are capable of modulating their secretory activity in response to changes in blood glucose. Even a minimal residual insulin secretion is of metabolic significance.